Meet the Cohort 2018/19
Operon (formerly Coli)
Multiplatform lab work management application
Operon aims to improve the efficiency of science with software. Science is held back by the way scientists manage their lab work. Operon is a multiplatform ELN application to easily set up, execute and record experiments from the desktop to the bench-top. Unlike competitors, it is both easy-to-use and ready for bench-top integration.
Elderly care app that helps you checks on loved ones
AllGood was founded on the belief that families shouldn't have to worry about their elderly loved ones living alone. All current solutions entail functional, emotional, and economic compromises. As 40% of seniors have a smartphone, AllGood decided to solve this problem with a simple mobile application. It provides an alternative to obsolete panic buttons (of which half are never worn).
Neurolytics (formerly Rebndl)
Intelligent digital news subscription
Rebndl is on the verge of transforming the news publishing industry. Currently, 67% of people read the news online for free, and are increasingly looking to access a highly curated selection of news stories on their smartphones. Through its digital news subscription platform, Rebndl integrates the emerging trends in news consumption behaviour with the changing business demands of newspapers to shape the future of news publishing.
After having been equipped with the skills needed to found a start-up in the OX1 Incubator, the original Rebndl team moved on to a new idea: Neurolytic Healthcare Ltd. They have already received funding from two sources and have a headcount of 10 dedicated team members including a prominent advisory board.
Neurolytic Healthcare Ltd. delivers AI-driven real-time event prediction and pharmacogenomic testing for neurological disorders to improve patient quality of life and help clinicians optimise prescription decisions. It draws on recent advances and successes in personalised medicine and pharmacogenomics, supported by NHS England's aim to embed personalised healthcare across the NHS. Given the current suboptimal management of neurological disorders and lack of specialised healthcare staff in the UK, there remains a significant unmet need for digital healthcare providers who can deliver effective neurological event prediction prediction tools and a systematic optimisation of pharmacological treatment. By covering and personalising the complete treatment pathway, Neurolytic Healthcare ensures improved quality of life and optimised clinical decision-making, whilst reducing the significant costs to the economy and healthcare system.
Art marketplace platform developing limited editions of art derivatives
The Chinese Authorised Art Derivatives market has an estimated size of 10 billion USD. Yet, it still has untapped opportunities. Artale addresses four primary issues faced by artists (lack of knowledge of how to monetise their art beyond galleries; lack of motivation to seek potential buyers; no market for the transactions of mid-tier artists’ works; and limited digital means to display and sell their art) and two issues faced by customers (middle income families do not have sufficient income to purchase high end artworks; and many potential customers are unaware of the range of offerings of the art market).
App using CBT to overcome the fear of needles
The current solutions to a fear of needs (talking therapies, distraction and relaxation) are either ineffective or expensive and inconvenient. Intrepidus provides convenient, low-cost, therapy-quality care to help people overcome their fear of needles. It does so via an app powered by AI and CBT which identifies and challenges patients’ fears and unhelpful thoughts and behaviours.
Fresh pasta making robot
Ceres tackles the ‘hungry person’s trilemma’: when choosing between convenient, affordable and healthy food, you can generally have at most two of the three. This trilemma is most noteworthy during the lunchtime rush, which presents a lucrative opportunity: the lunchtime market in the UK is £5 billion per annum and growing.
Ceres is creating a high-end pasta making robot that can deliver a fresh pasta meal from order to service in less than 3 minutes.
Welcome to OX1 Incubator Demo Day 2023! 🚀
May 5th, 4pm | Lecture Theatre 2, Mathematical Institute, Oxford
What is OX1?
OX1 is an incubator program for student-founded startups at the University of Oxford. We take in Oxford students and guide them to spot problems, develop ideas, and build a formidable team.
Our start-ups move fast, and exciting things keep happening:
Mable (OX1 2018/19), a migraine care start-up, graduated from Y-Combinator’s S21 batch and raised >$3 million in seed funding
Earthwise (OX1 2021/22, prev. Climaview), that helps sustainability businesses increase their revenue, raised a pre-seed round and is launching a pilot with a major UK bank within a year of launch
Caviar (OX1 2021/22, prev. Danu), an NFT AMM startup has raised a VC-backed pre-seed round and strategic angel round within a year of launch
What is going to happen this Demo Day?
Out of our 60+ cohort members, selected start-ups will compete for £18,000 of equity-free grants.
The Magdalen College Grand Prize
£10,000 cash, alongside £5,000 of credits for the use of the Science Park
Christ Church S.S. Chang Memorial Prize
The Byrne Award for Entrepreneurship
4:10 - 6:10
Layers brings the 3rd dimension into your personal workspace
ML-based property portal that helps users find their perfect home
Francisco Girbal Eiras
Analysing dematoglyphics data to detect markers that correspond to genetic disorders
Nithishwer M. Anand
Antigen platform that develops new bispecific antibodies for solid cancer tumours
Chewing gum that delivers 9 vitamins directly into bloodstream
Angharad J. Buxton
6:10 - 6:20
The judges will award the £18,000 of prize grants.
6:20 - 7:00
Welcome to network with fellow attendees along some refreshments!
Join our rocketship and get to know the best entrepreneurial talents in Oxford🚀